Search by Drug Name or NDC
NDC 70954-0157-20 Clorazepate Dipotassium 15 mg/1 Details
Clorazepate Dipotassium 15 mg/1
Clorazepate Dipotassium is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ANI Pharmaceuticals, Inc.. The primary component is CLORAZEPATE DIPOTASSIUM.
MedlinePlus Drug Summary
Clorazepate is used to relieve anxiety. Clorazepate is also used along with other medications to treat certain types of seizures. It is also used to relieve unpleasant symptoms that may be experienced by people who have stopped drinking alcohol after drinking large amounts for a long time. Clorazepate is in a class of medications called benzodiazepines. It works by decreasing abnormal electrical activity in the brain.
Related Packages: 70954-0157-20Last Updated: 05/12/2024
MedLinePlus Full Drug Details: Clorazepate
Product Information
| NDC | 70954-0157 |
|---|---|
| Product ID | 70954-157_23835ed6-9802-4fb5-88ef-bef2655db16c |
| Associated GPIs | |
| GCN Sequence Number | 003744 |
| GCN Sequence Number Description | clorazepate dipotassium TABLET 15 MG ORAL |
| HIC3 | H20 |
| HIC3 Description | ANTI-ANXIETY - BENZODIAZEPINES |
| GCN | 14090 |
| HICL Sequence Number | 001612 |
| HICL Sequence Number Description | CLORAZEPATE DIPOTASSIUM |
| Brand/Generic | Generic |
| Proprietary Name | Clorazepate Dipotassium |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Clorazepate Dipotassium |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 15 |
| Active Ingredient Units | mg/1 |
| Substance Name | CLORAZEPATE DIPOTASSIUM |
| Labeler Name | ANI Pharmaceuticals, Inc. |
| Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA213730 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70954-0157-20 (70954015720)
| NDC Package Code | 70954-157-20 |
|---|---|
| Billing NDC | 70954015720 |
| Package | 30 TABLET in 1 BOTTLE (70954-157-20) |
| Marketing Start Date | 2023-08-24 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.7969 |
| Pricing Unit | EA |
| Effective Date | 2024-01-17 |
| NDC Description | CLORAZEPATE 15 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis